Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.5400
Nov 20 • 3:59 PM ET Dollar change-0.0805 Percentage change(-12.97%)
Aftermarket Close
0.5181
Aftermarket • 7:57 PM ET Dollar change-0.0219 Percentage change(-4.06%)
Index
-
Market Cap
29.23M
Enterprise Value
12.73M
Income
-49.54M
Sales
10.56M
Book/sh
0.46
Cash/sh
0.36
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
127
IPO
Apr 11, 2011
P/E
-
Forward P/E
-
PEG
-
P/S
2.77
P/B
1.17
P/C
1.52
P/FCF
-
EV/EBITDA
-
EV/Sales
1.21
Quick Ratio
2.64
Current Ratio
2.99
Debt/Eq
0.13
LT Debt/Eq
0.08
Option/Short
Yes / Yes
EPS (ttm)
-0.59
EPS next Y
-0.37
EPS next Q
-0.10
EPS this Y
28.95%
EPS next Y
32.10%
EPS next 5Y
25.57%
EPS past 3/5Y
31.40% 35.83%
Sales past 3/5Y
20.19% 29.29%
EPS Y/Y TTM
29.98%
Sales Y/Y TTM
35.75%
EPS Q/Q
34.10%
Sales Q/Q
-11.14%
Insider Own
28.87%
Insider Trans
4.44%
Inst Own
36.81%
Inst Trans
-5.65%
ROA
-88.43%
ROE
-115.38%
ROIC
-211.12%
Gross Margin
12.62%
Oper. Margin
-467.67%
Profit Margin
-469.09%
SMA20
-12.87%
SMA50
-11.38%
SMA200
-45.92%
Trades
Shs Outstand
47.12M
Shs Float
38.50M
52W High
2.17 -75.12%
52W Low
0.43 26.94%
Volatility
16.61% 18.87%
ATR (14)
0.11
RSI (14)
43.69
Beta
0.68
Rel Volume
2.84
Avg Volume
223.61K
Volume
634,010
Perf Week
-16.16%
Perf Month
18.68%
Perf Quarter
-37.92%
Perf Half Y
-46.00%
Perf YTD
-69.66%
Perf Year
-68.24%
Perf 3Y
-80.58%
Perf 5Y
-85.52%
Perf 10Y
-100.00%
Prev Close
0.62
Price
0.54
Change %
-12.97%
Consensus
Strong Buy
Avg. Price Target
$2.67
Implied Upside
+394.4%
Analysts3incl. previous ratings
Rating Distribution2 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Feb 02, 2026Initiated
MMaxim Group
Buy$6+1,011.1%
Jan 07, 2016Initiated
RRodman & Renshaw
Buy$4+640.7%
Mar 13, 2015Downgrade
OPY logoOOppenheimer
Outperform → Perform
Nov 26, 2013Initiated
OPY logoOOppenheimer
Outperform$6+1,011.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stuka PaulDirectorNov 17 '26Buy0.5830,00017,400697,871Nov 19 04:05 PM
Stuka PaulDirectorNov 13 '26Buy0.65307,693200,000731,397Nov 17 04:05 PM
Lawless Michael AChief Financial OfficerNov 13 '26Buy0.65115,38575,000807,080Nov 17 04:05 PM
BERMAN MICHAELDirectorNov 13 '26Buy0.6576,92350,000429,509Nov 17 04:05 PM
Slosman MarvinCEO and PresidentNov 13 '26Buy0.6546,15430,0003,602,812Nov 17 04:05 PM
ROUBIN GARY SDirectorNov 13 '26Buy0.65153,846100,000988,324Nov 17 04:05 PM
Stuka PaulDirectorMay 27 '26Buy0.8820,00017,500667,871May 29 04:05 PM
Gleason Shane ThomasChief Commercial OfficerMay 19 '26Sale1.0122,77823,0061,053,882May 21 05:16 PM
Gleason Shane ThomasChief Commercial OfficerFeb 02 '26Sale1.592,9414,6761,076,660May 21 05:16 PM
Stuka PaulDirectorMay 13 '26Buy1.1610,00011,575642,871May 15 04:05 PM
Stuka PaulDirectorMay 14 '26Buy1.155,0005,750647,871May 15 04:05 PM
Slosman MarvinCEO and PresidentMay 12 '26Buy1.2021,00025,2003,556,658May 13 05:00 PM
Stuka PaulDirectorMay 08 '26Buy1.1665,62676,126622,871May 12 07:35 PM
Stuka PaulDirectorMay 11 '26Buy1.1910,00011,900632,871May 12 07:35 PM
Ward Scott R.DirectorMay 07 '26Buy1.1573,25584,243237,096May 08 05:08 PM
Ward Scott R.DirectorMay 06 '26Buy1.1515,99518,394163,841May 08 05:08 PM
Stuka PaulDirectorMay 07 '26Buy1.156,3787,335531,599May 08 05:05 PM
Stuka PaulDirectorMay 06 '26Buy1.121,5171,699525,221May 08 05:05 PM
ROUBIN GARY SDirectorMay 07 '26Buy1.1890,000106,200834,478May 08 05:03 PM
Gleason Shane ThomasChief Commercial OfficerJan 21 '26Sale1.6217,59328,5531,174,664Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 28 '26Sale1.6512,39520,4641,149,077Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 22 '26Sale1.578,41113,2391,166,253Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 29 '26Sale1.655,0008,2501,144,077Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 27 '26Sale1.664,7817,9561,161,472Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 30 '26Sale1.632,9004,7301,141,177Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 20 '26Sale1.592,9554,7101,192,257Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 15 '26Sale1.582,9094,5931,197,462Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerJan 16 '26Sale1.612,2503,6271,195,212Feb 02 05:01 PM
Gleason Shane ThomasChief Commercial OfficerFeb 02 '26Sale1.602,0003,2081,139,177Feb 02 05:01 PM
Stuka PaulDirectorDec 09 '25Buy1.815,0739,182391,628Dec 11 04:05 PM
Stuka PaulDirectorDec 05 '25Buy1.865,0739,436388,918Dec 08 04:05 PM
Stuka PaulDirectorDec 04 '25Buy1.8510,13018,740383,845Dec 05 04:05 PM
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.
PresidentMr. Marvin L. Slosman
CFOMr. Michael A. Lawless
Senior Vice President of Global Operations & EngineeringMr. Vince Turturro
Senior Vice President of Global Sales & MarketingMs. Kathleen Kennedy
Vice President of Human Resources & Organizational DevelopmentMs. Donna DeChant